These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26184673)

  • 1. Reactive stroma in the prostate during late life: The role of microvasculature and antiangiogenic therapy influences.
    Montico F; Kido LA; San Martin R; Rowley DR; Cagnon VH
    Prostate; 2015 Oct; 75(14):1643-61. PubMed ID: 26184673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of anti-inflammatory and antiangiogenic therapies negatively influences prostate cancer progression in TRAMP mice.
    Mateus PAM; Kido LA; Silva RS; Cagnon VHA; Montico F
    Prostate; 2019 Apr; 79(5):515-535. PubMed ID: 30585351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Montico F; Kido LA; Hetzl AC; Cagnon VH
    Prostate; 2015 Apr; 75(5):484-99. PubMed ID: 25521760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic and finasteride therapies: responses of the prostate microenvironment in elderly mice.
    Kido LA; Hetzl AC; Cândido EM; Montico F; Lorencini RM; Cagnon VH
    Life Sci; 2014 Jun; 106(1-2):58-70. PubMed ID: 24792519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
    Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
    Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic therapy effects on age-associated matrix metalloproteinase-9 (MMP-9) and insulin-like growth factor receptor-1 (IGFR-1) responses: a comparative study of prostate disorders in aged and TRAMP mice.
    Montico F; Kido LA; Hetzl AC; Lorencini RM; Cândido EM; Cagnon VH
    Histochem Cell Biol; 2014 Sep; 142(3):269-84. PubMed ID: 24562790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
    McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
    Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
    Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
    Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
    Yang F; Strand DW; Rowley DR
    Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches.
    Kido LA; de Almeida Lamas C; Maróstica MR; Cagnon VHA
    Life Sci; 2019 Jan; 217():141-147. PubMed ID: 30528182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobe-specific responses of TRAMP mice dorsolateral prostate following celecoxib and nintedanib therapy.
    Montico F; Lamas CA; Rossetto IMU; Baseggio AM; Cagnon VHA
    J Mol Histol; 2023 Aug; 54(4):379-403. PubMed ID: 37335420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nintedanib treatment delays prostate dorsolateral lobe cancer progression in the TRAMP model: contribution to the epithelial-stromal interaction balance.
    Nogueira Pangrazi E; da Silva RF; Kido LA; Montico F; Cagnon VHA
    Cell Biol Int; 2018 Feb; 42(2):153-168. PubMed ID: 28980742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis and prostate cancer: identification of a molecular progression switch.
    Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM
    Cancer Res; 2001 Mar; 61(6):2736-43. PubMed ID: 11289156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic therapy with Nintedanib affects hypoxia, angiogenesis and apoptosis in the ventral prostate of TRAMP animals.
    da Silva RF; Banzato TP; Alves LF; Carvalho JE; Agarwal R; Cagnon VHA
    Cell Tissue Res; 2020 Feb; 379(2):407-420. PubMed ID: 31473819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis.
    Yang F; Tuxhorn JA; Ressler SJ; McAlhany SJ; Dang TD; Rowley DR
    Cancer Res; 2005 Oct; 65(19):8887-95. PubMed ID: 16204060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia.
    Wang L; Xie L; Tintani F; Xie H; Li C; Cui Z; Wan M; Zu X; Qi L; Cao X
    Stem Cells Transl Med; 2017 Feb; 6(2):394-404. PubMed ID: 28191756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
    Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model.
    Isayeva T; Chanda D; Kallman L; Eltoum IE; Ponnazhagan S
    Cancer Res; 2007 Jun; 67(12):5789-97. PubMed ID: 17575146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes.
    Webber JP; Spary LK; Mason MD; Tabi Z; Brewis IA; Clayton A
    Oncotarget; 2016 Apr; 7(15):20124-39. PubMed ID: 26934553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reactive stroma microenvironment and prostate cancer progression.
    Barron DA; Rowley DR
    Endocr Relat Cancer; 2012 Dec; 19(6):R187-204. PubMed ID: 22930558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.